In defense of a regulated market in kidneys from living vendors

Journal of Medicine and Philosophy

Volumn 30, Issue 6, 2005, Pages 593-626

  Hippen, Benjamin E ^a  

^a Metrolina Nephrology Associates   (United States)

Author keywords

Kidney failure; Kidney transplantation; Organ donation; Organ market; Organ trafficking; Organ vendor

Indexed keywords

ALTRUISM; CONFLICT OF INTEREST; COST BENEFIT ANALYSIS; GOVERNMENT REGULATION; GRAFT RECIPIENT; HEALTH CARE COST; HUMAN; INTERNET; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LAW; LIVING DONOR; MARKETING; MEDICOLEGAL ASPECT; MORALITY; ORGAN DONOR; PATIENT SAFETY; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; SAFETY;

ANALYTICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

ALTRUISM; COMMERCE; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MOTIVATION; TISSUE AND ORGAN PROCUREMENT;

EID: 30544451307     PISSN: 03605310     EISSN: None     Source Type: Journal    
DOI: 10.1080/03605310500421397     Document Type: Review

References (73)

1. OPTN/SRTR Annual Report: Transplant Data 1993-2002. [On-line]. Available: http://www.ustransplant.org.
2. (1984). National Organ Transplant Act. 42 USC 273. 42 USC 273: 2339-2348.
3. (2005). USRDS 2004 annual data report. American Journal of Kidney Diseases, 45(1 Pt 2), 8-280.
4. (Census 2000). U.S. Census Bureau - Table: QT-P1Age Groups and Sex. [On-line]. Available: http://factfinder.census.gov/.
5. Abecassis, M., Adams, M., & et al. (2000). Consensus statement on the live organ donor. Journal of the American Medical Association, 284(22), 2919-2926.
6. Buchanan, J.M. (2000). The limits of liberty: Between anarchy and leviathan (The collected works of James Buchanan, Volume 7). Indianapolis: Liberty Fund.
7. Caplan, A.L. (2004). Transplantation at any price?. American Journal of Transplantation, 4(12), 1933-1934.
8. Cherry, M.J. (2000). Is a market in human organs necessarily exploitative?. Public Affairs Quarterly, 14(4), 337-360.
9. Childress, J.F. (1992). The body as property: some philosophical reflections. Transplantion Proceedings, 24(5), 2143-8 discussion 2149-2951.
10. Chugh, K.S., & Jha, V. (2000). Problems and outcomes of living unrelated donor transplants in the developing countries. Kidney International, 57(s74), 131-135.
11. Chugh, K.S., & Jha, V. (1996). Commerce in transplantation in Third World countries. Kidney International, 49, 1181-1186.
12. Cohen, L.R. (1989). Increasing the supply of transplant organs: The virtue of a futures market. George Washington Law Review, 58, 1-51.
13. Davis, C.L. (2004). Evaluation of the living kidney donor: current perspectives. American Journal of Kidney Diseases, 43(3), 508-530.
14. Delmonico, F.L., Arnold, R., & et al. (2002). Ethical incentives - not payment - for organ donation. New England Journal of Medicine, 346(25), 2002-2005.
15. Delmonico, F.L., Morrissey, P.E., & et al. (2004). Donor kidney exchanges. American Journal of Transplantion, 4(10), 1628-1634.
16. Delmonico, F.L., & Scheper-Hughes, N. (2002). Why we should not pay for human organs. The National Catholic Bioethics Quarterly, 2(3), 381-389.
17. Delmonico, F.L., & Scheper-Hughes, N. (2003). Why we should not pay for human organs. Zygon, 38(3), 689-698.
18. Ellison, M.D., McBride, M.A., & et al. (2002). Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. Transplantation, 74(9), 1349-1351.
19. Engelhardt, H.T. (1996). The foundations of bioethics , 2nd ed. New York: Oxford University Press.
20. Engelhardt, H.T. (2004). Giving, selling and having taken: Conflicting views of organ transfer. Indiana Health Law Review, 1(1), 31-49.
21. Epstein, R.A. (1995). Simple rules for a complex world. Cambridge, MA: Harvard University Press.
22. Fox, R.C., & Swazey, J.P. (1992). Spare parts: Organ replacement in American society. New York: Oxford University Press.
23. Gilbert, J.C., Brigham, L., & et al. (2005). The nondirected living donor program: a model for cooperative donation, recovery and allocation of living donor kidneys. American Journal of Transplantation, 5(1), 167-174.
24. Gossmann, J., Wilhelm, A., & et al. (2005). Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center. American Journal of Transplantation, 5(10), 2417-2424.
25. Goyal, M., Mehta, R.L., & et al. (2002). Economic and health consequences of selling a kidney in India. Journal of the American Medical Association, 288(13), 1589-1593.
26. Grazer, F.M., & de Jong, R.H. (2000). Fatal outcomes from liposuction: census survey of cosmetic surgeons. Plastic and Reconstructive Surgery, 105(1), 436-46 discussion 447-448.
27. Haustein, S.V., & Sellers, M.T. (2004). Factors associated with (un)willingness to be an organ donor: importance of public exposure and knowledge. Clinical Transplantation, 18(2), 193-200.
28. Higgins, R., West, N., & et al. (2003). Kidney transplantation in patients travelling from the UK to India or Pakistan. Nephrology, Dialysis, Transplantation, 18(4), 851-852.
29. Israni, A.K., Halpern, S.D., & et al. (2005). Incentive models to increase living kidney donation: encouraging without coercing. American Journal of Transplantation, 5(1), 15-20.
30. Ivanovski, N., Stojkovski, L., & et al. (1997). Renal transplantation from paid, unrelated donors in India - it is not only unethical, it is also medically unsafe. Nephrology, Dialysis, Transplantation, 12(9), 2028-2029.
31. Jacobs, C.L., Roman, D., & et al. (2004). Twenty-two nondirected kidney donors: an update on a single center's experience. American Journal of Transplantation, 4(7), 1110-1116.
32. Jha, V. (2004). Paid transplants in India: the grim reality. Nephrology, Dialysis, Transplantation, 19(3), 541-543.
33. Kahn, J.P., & Delmonico, F.L. (2004). The consequences of public policy to buy and sell organs for transplantation. American Journal of Transplantation, 4(2), 178-180.
34. Kasiske, B.L., Cangro, C.B., & et al. (2002). The evaluation of renal transplantation candidates: clinical practice guidelines. American Journal of Transplantion, 1(Suppl 2), 1-95.
35. Lawrence, R. (1997). Abuse of live related kidney transplantation. Nephrology, Dialysis, Transplantation, 12(9), 2028.
36. Lee, Y.H., Huang, W.C., & et al. (1994). The long-term stone recurrence rate and renal function change in unilateral nephrectomy urolithiasis patients. The Journal of Urology, 152(5 Pt 1), 1386-1388.
37. Machan, T.R. (1997). Blocked exchanges revisited. Journal of Applied Philosophy, 14(3), 249-262.
38. Matas, A.J. (2004). The case for living kidney sales: rationale, objections and concerns. American Journal of Transplantation, 4(12), 2007-2017.
39. Matas, A.J., Bartlett, S.T., & et al. (2003). Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. American Journal of Transplantation, 3(7), 830-834.
40. Matas, A.J., & Schnitzler, M. (2004). Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. American Journal of Transplantation, 4(2), 216-221.
41. Meier-Kriesche, H.U., & Kaplan, B. (2002). Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation, 74(10), 1377-1381.
42. Nozick, R. (1975). Anarchy, state, and utopia. Oxford: Blackwell.
43. Ojo, A.O., Hanson, J.A., & et al. (2001). Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. Journal of the American Society for Nephrology, 12(3), 589-597.
44. Oniscu, G.C., Brown, H., & et al. (2004). How old is old for transplantation?. American Journal of Transplantation, 4(12), 2067-2074.
45. Pence, G. (2002, April 9). Organ donors risk health. Los Angeles Times, B13.
46. Prottas, J.M. (1992). Buying human organs - evidence that money doesn't change everything. Transplantation, 53(6), 1371-1373.
47. Radcliffe-Richards, J., Daar, A.S., Guttman, R.D., Hoffenberg, R., Kennedy, I., Lock, M., Sells, R.A., & Tilney, N. (1998). The case for allowing kidney sales. Lancet, 351, 1950-1952.
48. Radin, M.J. (1996). Contested commodities. Cambridge: Harvard University Press.
49. Reddy, K.C., Thiagarajan, C.M., & et al. (1990). Unconventional renal transplantation in India. Transplantation Proceedings, 22(3), 910-911.
50. Scheper-Hughes, N. (2000). The global traffic in human organs. Current Anthropology, 41(2), 191-224.
51. Scheper-Hughes, N. (2001). Commodity fetishism in organs trafficking. Body Society, 7(2-3), 31-62.
52. Scheper-Hughes, N. (2002). The ends of the body: Commodity fetishism and the global traffic in organs. SAIS Review, XXII(1), 61-80.
53. Schwartz, J. (1999). Blood and altruism - Richard M. Titmuss' criticism on the commercialization of blood. Public Interest, 136 (Summer, 1999).
54. Sehgal, A.R. (2004). The net transfer of transplant organs across race, sex, age, and income. The American Journal of Medicine, 117(9), 670-675.
55. Sever, M.S., Kazancioglu, R., & et al. (2001). Outcome of living unrelated (commercial) renal transplantation. Kidney International, 60(4), 1477-1483.
56. Shakespeare, W. (1974). The Riverside Shakespeare. Boston: Houghton Mifflin Company.
57. Siminoff, L.A., Arnold, R.M., & et al. (2001). The process of organ donation and its effect on consent. Clinical Transplantation, 15(1), 39-47.
58. Siminoff, L.A., & Saunders Sturm, C.M. (2000). African-American reluctance to donate: beliefs and attitudes about organ donation and implications for policy. Kennedy Institute for Ethics Journal, 10(1), 59-74.
59. Simon, T.L. (1998). Monetary compensation for plasma donors: a record of safety. Transfusion, 38(9), 883-886.
60. Sonnenday, C.J., Warren, D.S., & et al. (2004). Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. American Journal of Transplantation, 4(8), 1315-1322.
61. Starr, D.P. (1998). Blood: An epic history of medicine and commerce. New York: Alfred A. Knopf.
62. Strauss, R.G. (2001). Blood donations, safety, and incentives. Transfusion, 41(2), 165-167.
63. Surman, O.S., Fukunishi, I., Allen, T., & Hertl, M. (2005). Live organ donation: Social context, clinical encounter, and the psychology of communication. Psychosomatics, 46(1), 1-6.
64. Textor, S.C., Taler, S.J., & et al. (2003). Blood pressure evaluation among older living kidney donors. The Journal of the American Society for Nephrology, 14(8), 2159-2167.
65. Thiagarajan, C.M., Reddy, K.C., & et al. (1990). The practice of unconventional renal transplantation (UCRT) at a single centre in India. Transplantation Proceedings, 22(3), 912-914.
66. Tiong, B.C. (2001). Human organ transplants. In A. Tan-Alora & J.M. Lumitao (eds.), Beyond a western bioethics: Voices from the developing world. Washington, DC: Georgetown University Press.
67. Titmuss, R.M. (1970). The gift relationship: From human blood to social policy. London: Allen & Unwin.
68. Tyden, G., Kumlien, G., & et al. (2003). Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation, 76(4), 730-731.
69. Veatch, R.M. (2003). Why liberals should accept financial incentives for organ procurement. Kennedy Institute for Ethics Journal, 13(1), 19-36.
70. Warren, D.S., Zachary, A.A., & et al. (2004). Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers. American Journal of Transplantation, 4(4), 561-568.
71. Xue, J.L., Ma, J.Z., & et al. (2001). Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. The Journal of the American Society for Nephrology, 12(12), 2753-2758.
72. Yen, F.F., Hardinger, K., & et al. (2004). Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. American Journal of Transplantation, 4(10), 1703-1708.
73. Zargooshi, J. (2001). Quality of life of Iranian kidney "donors". The Journal of Urology, 166(5), 1790-1799.